NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin. 1993

A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
Department of Psychology, University of New Orleans, Lakefront, LA 70148.

Subcutaneous injection of formalin produces a biphasic pain response: an early, transient phase followed by a late tonic phase. The present study examined the involvement of the N-methyl-D-aspartic acid (NMDA) receptor in the development of the late pain produced following subcutaneous injection of formalin into the hind paw in mice. Blockade of the NMDA receptor by its non-competitive antagonist, MK-801, prior to formalin injection, but not after, reduced pain during the late phase. Similarly, blockade of the NMDA receptor allosteric site by the novel glycine site antagonist, ACEA-1011, also reduced the pain response in the late phase. These results suggest that the development of the late phase of formalin pain is due to NMDA-mediated activity during the early phase.

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D011810 Quinoxalines Quinoxaline
D005528 Foot The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones. Feet
D005557 Formaldehyde A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717) Formalin,Formol,Methanal,Oxomethane
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001522 Behavior, Animal The observable response an animal makes to any situation. Autotomy Animal,Animal Behavior,Animal Behaviors

Related Publications

A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
February 1994, European journal of pharmacology,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
January 1994, Acta neurochirurgica. Supplementum,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
January 1995, NIDA research monograph,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
September 1996, Pharmacology, biochemistry, and behavior,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
August 1989, European journal of pharmacology,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
January 1991, European journal of pharmacology,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
January 1989, Psychopharmacology,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
July 2000, Brain research. Developmental brain research,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
March 1991, Pharmacology, biochemistry, and behavior,
A L Vaccarino, and P Marek, and B Kest, and E Weber, and J F Keana, and J C Liebeskind
September 1989, Brain research,
Copied contents to your clipboard!